Regenicin Inc Quick Ratio (RGIN) starting from the second quarter 2023 to second quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Regenicin Inc   (RGIN)

Regenicin Inc 's Quick Ratio

RGIN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2023, Quick Ratio fell to 0.6 above Regenicin Inc average.

Within Medical Equipment & Supplies industry 162 other companies have achieved higher Quick Ratio than Regenicin Inc in second quarter 2023. While Quick Ratio total ranking in the second quarter 2023 has deteriorated compared to the prior quarter from 2617 to 2748.

Explain Quick Ratio?
How much Cash & cash equivalents RGIN´s has?
What are RGIN´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RGIN Quick Ratio (Mar 31 2023)
Q2		 (Dec 31 2022)
Q1		 (Sep 30 2022)
Q4		 (Jun 30 2022)
Q3		 (Mar 31 2022)
Q2
Y / Y Current Liabilities Change 242.09 % 245.25 % 13.1 % 12.24 % 12.76 %
Y / Y Cash & cash equivalent Change 635049.39 % 682812.62 % 683.7 % 420359.89 % 29.19 %
Quick Ratio MRQ 0.6 0.67 0 2.17 0
RGIN's Total Ranking # 2748 # 2617 # 5086 # 5512 # 4932
Seq. Current Liabilities Change 2.27 % 214.81 % 3.1 % 3.06 % 3.21 %
Seq. Cash & cash equivalent Change -7.75 % 80852.03 % -99.88 % 688393.87 % -0.81 %



Quick Ratio second quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 163
Healthcare Sector # 929
Overall Market # 2748


Quick Ratio Statistics
High Average Low
0.85 0.1 0
(Mar 31 2015)   (Jun 30 2014)




Financial Statements
Regenicin Inc 's Current Liabilities $ 18 Millions Visit RGIN's Balance sheet
Regenicin Inc 's Cash & cash equivalent $ 11 Millions Visit RGIN's Balance sheet
Source of RGIN's Sales Visit RGIN's Sales by Geography


Cumulative Regenicin Inc 's Quick Ratio

RGIN's Quick Ratio for the trailling 12 Months

RGIN Quick Ratio

 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth 131.51 % 73.37 % 13.24 % 13.84 % 14.1 %
Y / Y Cash & cash equivalent TTM Growth 425399.49 % 305771.23 % 160322.5 % 171649.62 % 48.18 %
Quick Ratio TTM 0.74 0.69 0.55 0.57 0
Total Ranking TTM # 4569 # 4236 # 4677 # 3611 # 4972
Seq. Current Liabilities TTM Growth 37.6 % 58.5 % 3.12 % 2.94 % 3.05 %
Seq. Cash & cash equivalent TTM Growth 46.09 % 99.83 % 0.11 % 145497.22 % 5.01 %

Quick ratio ranking by company, industry and sector >> Back to RGIN Financial Strength Comparisons >> Go to Compare RGIN Quick Ratio to its Competitors

On the trailing twelve months basis RGIN Cash & cash equivalent more than doubled by 635049.39 % in Q2 2023 year on year, faster than Current Liabilities, this led to increase in in Regenicin Inc 's Quick Ratio to 0.74, above RGIN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 251 other companies have achieved higher Quick Ratio than Regenicin Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2022 from 4236 to 4569.

Explain Quick Ratio?
How much Cash & cash equivalents RGIN´s has?
What are RGIN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 252
Healthcare Sector # 1182
Within the Market # 4569


trailing twelve months Quick Ratio Statistics
High Average Low
0.48 0.04 0
(Mar 31 2023)   (Mar 31 2021)




Companies with similar Quick Ratio in the quarter ending Mar 31 2023, within Medical Equipment & Supplies Industry Quick RatioMar 31 2023 MRQ Cash & cash equivalentMar 31 2023 MRQ Current Liabilities
Livanova Plc  1.65 $ 522.958  Millions$ 316.129  Millions
Edap Tms Sa  1.58 $ 48.688  Millions$ 30.908  Millions
Sharecare Inc   1.55 $ 154.430  Millions$ 99.551  Millions
Prosomnus Inc   1.54 $ 11.560  Millions$ 7.502  Millions
Icad Inc  1.53 $ 19.663  Millions$ 12.881  Millions
Apyx Medical Corp  1.52 $ 16.255  Millions$ 10.683  Millions
Pixie Dust Technologies Inc   1.52 $ 16.071  Millions$ 10.585  Millions
Minerva Surgical Inc   1.51 $ 25.255  Millions$ 16.694  Millions
Si bone inc   1.51 $ 22.969  Millions$ 15.227  Millions
Mimedx Group Inc   1.50 $ 61.221  Millions$ 40.870  Millions
Tactile Systems Technology Inc   1.47 $ 55.011  Millions$ 37.339  Millions
Harpoon Therapeutics Inc   1.39 $ 61.385  Millions$ 44.173  Millions
Penumbra Inc  1.36 $ 199.097  Millions$ 146.328  Millions
Endra Life Sciences Inc  1.29 $ 2.355  Millions$ 1.832  Millions
Lakeland Industries Inc   1.27 $ 26.021  Millions$ 20.533  Millions
Electromedical Technologies Inc   1.25 $ 1.235  Millions$ 0.988  Millions
Cerus Corporation  1.22 $ 94.680  Millions$ 77.573  Millions
Innovage Holding Corp   1.22 $ 167.553  Millions$ 137.689  Millions
Accuray Incorporated  1.18 $ 89.057  Millions$ 75.594  Millions
Biolife Solutions Inc   1.16 $ 54.885  Millions$ 47.319  Millions
Edwards Lifesciences Corporation  1.16 $ 1,254.200  Millions$ 1,082.000  Millions
Universal Biosensors Inc   1.14 $ 14.048  Millions$ 12.371  Millions
Haemonetics Corporation  1.13 $ 284.466  Millions$ 251.816  Millions
Surgalign Holdings Inc   1.12 $ 22.430  Millions$ 19.984  Millions
Docgo Inc   1.10 $ 120.057  Millions$ 108.975  Millions
Cadre Holdings inc   1.10 $ 48.294  Millions$ 43.868  Millions
Jin Medical International Ltd  1.09 $ 9.769  Millions$ 8.924  Millions
Integra Lifesciences Holdings Corp  1.09 $ 307.367  Millions$ 282.293  Millions
Brainsway Ltd   1.08 $ 10.520  Millions$ 9.761  Millions
Electromed Inc   1.06 $ 6.776  Millions$ 6.417  Millions

Date modified: 2026-09-08T15:10:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.